CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody.
about
Inducing and Administering Tregs to Treat Human DiseaseInteraction between natural killer cells and regulatory T cells: perspectives for immunotherapyEvans syndrome after unrelated bone marrow transplantation for refractory cytopenia of childhood.The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning.Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cellsAnti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice.Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of antilymphocyte serum treatment of rejection.Differential depletion of total T cells and regulatory T cells and prolonged allotransplant survival in CD3Ɛ humanized mice treated with polyclonal anti human thymocyte globulin.Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice.Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplantHost CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCTThe effects of immunosuppression on regulatory CD4(+)CD25(+) T cells: impact on immunosuppression selection in transplantation.Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.Moving to tolerance: clinical application of T regulatory cellsInduction of transplantation tolerance through regulatory cells: from mice to men.The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.Regulatory T cells: first steps of clinical application in solid organ transplantation.Differential sensitivity of regulatory and effector T cells to cell death: a prerequisite for transplant tolerance.Foxp3(+) regulatory T cells in mouse models of type 1 diabetesMechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation.Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4⁺ T cells and requires the presence of monocytes.A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model.The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.Transient depletion of dividing T lymphocytes in mice induces the emergence of regulatory T cells and dominant tolerance to islet allografts.Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice.Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cells.Regulatory T cells control autoimmunity following syngeneic bone marrow transplantation.Induction of allograft tolerance by monoclonal CD3 antibodies: a matter of timing.
P2860
Q26772723-16E288C6-784B-4BE6-93E8-1C4F8690DCB4Q27008625-C5AF05DC-92F1-4AB3-B565-3C8F6749A4EDQ33416796-FBA573DA-A915-418A-95DF-64D3ADFE9EE2Q33914718-AEB47843-BED7-4BF2-91FB-7FE0EF4D471BQ34333949-7EF78B69-CA67-4AC1-9F19-CB6F5EC504ACQ34511576-9ABE94A4-FB5A-4758-BC6E-74A595FDF81CQ35217526-113AEFAB-5614-4683-B2AC-D3D33A0A654BQ36296614-42BE21EE-2CE6-4037-8284-842B3B645188Q36449594-84862685-C6C7-4818-8B50-E559437BA695Q36862415-227D74AB-7A8C-48BF-9521-4157F9266A5EQ37066280-A3AC0ACA-26B3-4E11-8830-D6FDA7211066Q37176386-0F6C213E-751C-40C8-B024-27487DBCF932Q37338455-FEB5CA63-FDB3-4720-BDC3-C77385917A16Q37881151-21CF3D8B-D83A-40C9-AF02-36CD23534A01Q38187170-9FF800F1-DA7F-44C4-97EE-5036007AA947Q38424224-1D70E1C8-D92C-40DF-8C90-94C491BBE076Q38485004-35D5DEB2-072A-4C34-859C-7E396AE522F7Q38515353-4417F8A8-1365-4867-8FC2-4039A35F2311Q40509547-B573F1C5-2781-425F-8864-08F44B16B486Q41851877-D76B6F70-E9E8-4E9F-A8C7-1F8D75EFFAC5Q42639405-808539AB-01CD-4110-9691-2CF0AA225A6AQ42827367-2BA4BD7D-0D90-4A2C-A8AC-11EA4E96E0F7Q46142308-DCE10231-9AE3-4953-979E-D5BBD4DFF091Q46701386-81673A0E-60A6-460A-A8DA-96CCB865AEE3Q46763775-7C367446-9EE6-4E78-8D88-0AFE07B7246BQ47617412-689586A6-412A-47AB-8836-6EEB3A9CAF5DQ52008998-A4DAFBFD-931A-4F5D-94D4-DED0D4CFD35EQ54297363-83B88ECC-403E-4B51-BA9B-E807B70640AC
P2860
CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
CD4+ regulatory T cells are sp ...... lyclonal anti-T cell antibody.
@en
CD4+ regulatory T cells are sp ...... lyclonal anti-T cell antibody.
@nl
type
label
CD4+ regulatory T cells are sp ...... lyclonal anti-T cell antibody.
@en
CD4+ regulatory T cells are sp ...... lyclonal anti-T cell antibody.
@nl
prefLabel
CD4+ regulatory T cells are sp ...... lyclonal anti-T cell antibody.
@en
CD4+ regulatory T cells are sp ...... lyclonal anti-T cell antibody.
@nl
P2093
P1476
CD4+ regulatory T cells are sp ...... lyclonal anti-T cell antibody.
@en
P2093
Keisuke Minamimura
Takashi Maki
P304
P356
10.4049/JIMMUNOL.176.7.4125
P407
P577
2006-04-01T00:00:00Z